0001246360-17-000341.txt : 20170126 0001246360-17-000341.hdr.sgml : 20170126 20170126184911 ACCESSION NUMBER: 0001246360-17-000341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170124 FILED AS OF DATE: 20170126 DATE AS OF CHANGE: 20170126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NxStage Medical, Inc. CENTRAL INDEX KEY: 0001333170 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043454702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: 978-687-4700 MAIL ADDRESS: STREET 1: 350 MERRIMACK STREET CITY: LAWRENCE STATE: MA ZIP: 01843 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Robert S. CENTRAL INDEX KEY: 0001382096 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51567 FILM NUMBER: 17551269 MAIL ADDRESS: STREET 1: NXSTAGE MEDICAL INC STREET 2: 439 SOUTH UNION STREET 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 FORMER NAME: FORMER CONFORMED NAME: Brown Robert DATE OF NAME CHANGE: 20061127 4 1 form.xml PRIMARY DOCUMENT X0306 4 2017-01-24 false 0001333170 NxStage Medical, Inc. NXTM 0001382096 Brown Robert S. 350 MERRIMACK STREET LAWRENCE MA 01843 false true false false President, NxStage Kidney Care Common Stock 2017-01-24 4 M false 15000 11.03 A 55564 D Common Stock 2017-01-24 4 S false 15000 25.86 D 40564 D Common Stock 2017-01-25 4 M false 20000 11.03 A 60564 D Common Stock 2017-01-25 4 S false 20000 26.13 D 40564 D Common Stock 2017-01-26 4 M false 7000 11.03 A 47564 D Common Stock 2017-01-26 4 S false 7000 26.25 D 40564 D Stock Option (Right to Buy) 11.03 2017-01-24 4 M false 15000 0 D 2013-04-04 2023-03-03 Common Stock 15000 35897 D Stock Option (Right to Buy) 11.03 2017-01-25 4 M false 20000 0 D 2013-04-04 2023-03-03 Common Stock 20000 15897 D Stock Option (Right to Buy) 11.03 2017-01-26 4 M false 7000 0 D 2013-04-04 2023-03-03 Common Stock 7000 8897 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $25.75 to $26.04, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $26.02 to $26.29, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $26.04 to $26.42, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. Aras Lapinskas, attorney-in-fact for Robert Brown 2017-01-26